Smith & Nephew Completes Osiris Acquisition

By Julie A. Vetalice

Smith & Nephew (SNN) completed its acquisition of Osiris Therapeutics, provider of regenerative medicine products including skin, bone graft and articular cartilage substitutes. Osiris is now an indirect wholly-owned SNN subsidiary.

The acquisition is expected to accelerate growth from SNN's Advanced Wound Management segment. As previously noted, Osiris also brings BIO4® viable bone matrix, an alternative to autograft, and Cartiform® cryopreserved viable osteochondral allograft for articular cartilage repair.

Sources: Osiris Therapeutics, Inc.; Smith & Nephew plc; ORTHOWORLD Inc.

Product Labels: Orthobiologic Soft Tissue Repair

Tags: M&A